KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

Ekterly comes in the form of a 300 mg tablet. The recommended dosage is 600 mg split into two doses taken at the earliest sign of an attack, according to the prescribing information. Additional ...

There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...

Sarah Queen of Moulton faces charges of financial exploitation of the elderly in the first degree and elder neglect in the ...